<DOC>
	<DOCNO>NCT00644488</DOCNO>
	<brief_summary>The purpose clinical study ass safety tolerability BMS-641988 daily orally Japanese patient castration resistant prostate cancer</brief_summary>
	<brief_title>A Phase I Study BMS-641988 Japanese Patients With Castration Resistant Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients castrationresistant prostate cancer serum testosterone â‰¤50 ng/dL progressive current therapy satisfy inclusion exclusion criterion</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>